Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Jen Mains; Dimitrios Lamprou; Lisa McIntosh; Iain Oswald; Andrew Urquhart

doi:10.1039/C3CC41583J

Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Jen Mains, Dimitrios Lamprou, Lisa McIntosh, Iain Oswald, Andrew Urquhart

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

Original language	English
Pages (from-to)	5082-5084
Number of pages	3
Journal	Journal of the Chemical Society, Chemical Communications
Volume	49
Issue number	44
Early online date	23 Apr 2013
DOIs	https://doi.org/10.1039/C3CC41583J
Publication status	Published - 4 Jun 2013

Keywords

beta-adrenoceptor antagonists
amyloid nanostructure
drug delivery vehicles
amyloid hydrogels

Access to Document

10.1039/C3CC41583J

Cite this

@article{81fb3ceaf68e4b4c98d6d8b442c97c9b,

title = "Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles",

abstract = "Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.",

keywords = "beta-adrenoceptor antagonists, amyloid nanostructure, drug delivery vehicles, amyloid hydrogels",

author = "Jen Mains and Dimitrios Lamprou and Lisa McIntosh and Iain Oswald and Andrew Urquhart",

year = "2013",

month = jun,

day = "4",

doi = "10.1039/C3CC41583J",

language = "English",

volume = "49",

pages = "5082--5084",

journal = "Journal of the Chemical Society, Chemical Communications",

issn = "0022-4936",

publisher = "Royal Society of Chemistry",

number = "44",

}

TY - JOUR

T1 - Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

AU - Mains, Jen

AU - Lamprou, Dimitrios

AU - McIntosh, Lisa

AU - Oswald, Iain

AU - Urquhart, Andrew

PY - 2013/6/4

Y1 - 2013/6/4

N2 - Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

AB - Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

KW - beta-adrenoceptor antagonists

KW - amyloid nanostructure

KW - drug delivery vehicles

KW - amyloid hydrogels

U2 - 10.1039/C3CC41583J

DO - 10.1039/C3CC41583J

M3 - Article

SN - 0022-4936

VL - 49

SP - 5082

EP - 5084

JO - Journal of the Chemical Society, Chemical Communications

JF - Journal of the Chemical Society, Chemical Communications

IS - 44

ER -

Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Abstract

Keywords

Access to Document

Fingerprint

Cite this